Publicacións en colaboración con investigadores/as de Hospital Universitario San Juan de Alicante (160)

2025

  1. The CNIC polypill (Acetylsalicylic acid + Atorvastatin + Rampril) in secondary prevention of cardiovascular disease in patients with type 2 diabetes: A comparative analysis with alternative therapeutic approaches

    International Journal of Cardiology, Vol. 418

2024

  1. Applicability of the Zwolle score for selection of very high-risk ST-elevation myocardial infarction patients treated with primary angioplasty

    Angiology, Vol. 75, Núm. 2, pp. 175-181

  2. Classification tree obtained by artificial intelligence for the prediction of heart failure after acute coronary syndromes

    Medicina Clinica, Vol. 163, Núm. 4, pp. 167-174

  3. Design and validation of a new questionnaire with a gender perspective to measure medication adherence for secondary prevention of ischaemic heart disease: study protocol

    BMJ Open, Vol. 14, Núm. 3

  4. Heart failure biomarkers and prediction of early left ventricle remodeling after acute coronary syndromes

    Clinical Biochemistry, Vol. 131-132

  5. Predictive validity of the risk SCORE model in a Mediterranean population with arterial hypertension

    Medicina Clinica, Vol. 162, Núm. 3, pp. 112-117

  6. The CNIC-polypill (acetylsalicylic acid, atorvastatin, and ramipril), an effective and cost-saving secondary prevention strategy compared with other therapeutic options in patients with ischaemic heart disease

    European Heart Journal Open, Vol. 4, Núm. 2

2023

  1. Changes in circulating ApoJ-Glyc levels in patients with suspected acute coronary syndrome: The EDICA trial

    International Journal of Cardiology, Vol. 391

  2. Differences in weight loss and safety between the glucagon-like peptide-1 receptor agonists: A non-randomized multicenter study from the titration phase

    Primary Care Diabetes, Vol. 17, Núm. 4, pp. 366-372

  3. Differential prognosis of patients that are candidates for standard, short or prolonged dual antiplatelet treatment discharged after an acute coronary syndrome

    Thrombosis Research, Vol. 224, pp. 46-51

  4. Economic Burden Associated with the Treatment with a Cardiovascular Polypill in Secondary Prevention in Spain: Cost-Effectiveness Results of the NEPTUNO Study

    ClinicoEconomics and Outcomes Research, Vol. 15, pp. 559-571

  5. Effect of dapagliflozin on COVID-19 infection and risk of hospitalization

    The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 9, pp. 2335-2342

  6. Increased Risk of Heart Failure in Elderly Patients Treated with Beta-Blockers After AV Node Ablation

    American Journal of Cardiovascular Drugs, Vol. 23, Núm. 2, pp. 157-164

  7. Prognostic value of lipid profile awareness in patients admitted for a first acute coronary syndrome

    REC: CardioClinics

  8. Remnant cholesterol in patients admitted for acute coronary syndromes

    European journal of preventive cardiology, Vol. 30, Núm. 4, pp. 340-348

  9. Risk factors for major adverse cardiovascular events in postmenopausal women: UK Biobank prospective cohort study

    Atherosclerosis, Vol. 386

  10. The efficacy of intensive lipid-lowering therapies on the reduction of LDLc and of major cardiovascular events

    Journal of Clinical Lipidology, Vol. 17, Núm. 5, pp. 602-611

2022

  1. Anticoagulation in patients with valvular heart disease, beyond the rhythm

    REC: CardioClinics, Vol. 57, Núm. 4, pp. 231-233

  2. Antithrombotic Therapy in Elderly Patients with Acute Coronary Syndromes

    Journal of Clinical Medicine, Vol. 11, Núm. 11

  3. Clinical and therapeutic characterization of the ischemic cardiopathy in Spain. Importance of cardiac rehabilitation programs

    Medicina Clinica Practica, Vol. 5, Núm. 3